Dr. Anna Rothstein, M.D
NPI: 1801998109
Total Payments
$667.91
2024 Payments
$80.41
Companies
14
Transactions
26
Medicare Patients
2,203
Medicare Billing
$217,231
Payment Breakdown by Category
Food & Beverage$517.91 (77.5%)
Other$150.00 (22.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $517.91 | 25 | 77.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 22.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $150.00 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $104.62 | 3 | $0 (2023) |
| Shire North American Group Inc | $93.21 | 5 | $0 (2018) |
| Bausch & Lomb Americas Inc. | $75.53 | 4 | $0 (2024) |
| Horizon Therapeutics plc | $52.77 | 3 | $0 (2023) |
| AbbVie, Inc. | $42.41 | 2 | $0 (2017) |
| Astellas Pharma US Inc | $28.65 | 1 | $0 (2023) |
| Alcon Vision LLC | $23.02 | 1 | $0 (2023) |
| Merz Pharmaceuticals, LLC | $21.97 | 1 | $0 (2021) |
| RxSight Inc | $19.93 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.41 | 5 | Bausch & Lomb Americas Inc. ($51.23) |
| 2023 | $111.80 | 5 | Astellas Pharma US Inc ($28.65) |
| 2022 | $40.98 | 2 | Bausch & Lomb Americas Inc. ($24.30) |
| 2021 | $21.97 | 1 | Merz Pharmaceuticals, LLC ($21.97) |
| 2020 | $163.34 | 2 | Galderma Laboratories, L.P. ($150.00) |
| 2019 | $33.67 | 2 | Novartis Pharmaceuticals Corporation ($19.37) |
| 2018 | $114.90 | 4 | Novartis Pharmaceuticals Corporation ($67.80) |
| 2017 | $100.84 | 5 | Shire North American Group Inc ($46.11) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Allergy | ||||||
| 08/27/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/19/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Ophthalmology | ||||||
| 07/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Ophthalmology | ||||||
| 05/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Ophthalmology | ||||||
| 12/27/2023 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $28.65 | General |
| 10/19/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: TEPEZZA | ||||||
| 06/12/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Ophthalmology | ||||||
| 04/21/2023 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Ophthalmology | ||||||
| 12/30/2022 | Bausch & Lomb Americas Inc. | VICTUS (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Ophthalmology | ||||||
| 10/21/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: TEPEZZA | ||||||
| 04/26/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Musculoskeletal | ||||||
| 03/02/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: TEPEZZA | ||||||
| 02/27/2020 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| 12/10/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/30/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 12/17/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: OPTHALMICS | ||||||
| 09/25/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: OPTHALMICS | ||||||
| 09/24/2018 | Novartis Pharmaceuticals Corporation | BROLUCIZUMAB (Drug) | Food and Beverage | In-kind items and services | $67.80 | General |
| 06/12/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: OPTHALMICS | ||||||
| 12/06/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Immunology | ||||||
| 09/28/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: OPTHALMICS | ||||||
| 07/31/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Immunology | ||||||
| 06/19/2017 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $12.32 | General |
| Category: Medical Device (510K) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 604 | 625 | $116,455 | $57,330 |
| 2022 | 17 | 587 | 621 | $123,645 | $61,138 |
| 2021 | 17 | 601 | 633 | $114,797 | $61,077 |
| 2020 | 7 | 411 | 433 | $77,496 | $37,685 |
Total Patients
2,203
Total Services
2,312
Medicare Billing
$217,231
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 17 | 17 | $19,947 | $9,756 | 48.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 106 | 107 | $18,736 | $8,880 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 125 | $12,960 | $7,905 | 61.0% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 12 | 12 | $16,211 | $7,308 | 45.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 68 | 68 | $10,108 | $4,781 | 47.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $9,332 | $4,645 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 44 | $6,629 | $4,087 | 61.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 36 | 36 | $7,528 | $3,835 | 50.9% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 19 | 19 | $4,033 | $2,065 | 51.2% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 48 | 49 | $2,282 | $1,113 | 48.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 27 | $1,689 | $1,102 | 65.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 18 | 18 | $1,572 | $701.04 | 44.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 24 | 25 | $1,279 | $497.25 | 38.9% |
| 92134 | Imaging of retina | Office | 2023 | 15 | 15 | $849.02 | $441.56 | 52.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 22 | 22 | $3,300 | $212.96 | 6.5% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 21 | 21 | $26,193 | $12,787 | 48.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 104 | 106 | $18,391 | $8,120 | 44.2% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 12 | 12 | $16,737 | $7,174 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 73 | $10,946 | $6,654 | 60.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 89 | $9,172 | $5,649 | 61.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $8,151 | $4,189 | 51.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 38 | 38 | $7,800 | $3,396 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $5,636 | $2,931 | 52.0% |
| 68840 | Probing of nasal tear duct | Office | 2022 | 17 | 18 | $4,122 | $2,070 | 50.2% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 11 | 13 | $3,469 | $1,860 | 53.6% |
About Dr. Anna Rothstein, M.D
Dr. Anna Rothstein, M.D is a Ophthalmic Plastic and Reconstructive Surgery healthcare provider based in Canandaigua, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801998109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Rothstein, M.D has received a total of $667.91 in payments from pharmaceutical and medical device companies, with $80.41 received in 2024. These payments were reported across 26 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($517.91).
As a Medicare-enrolled provider, Rothstein has provided services to 2,203 Medicare beneficiaries, totaling 2,312 services with total Medicare billing of $217,231. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmic Plastic and Reconstructive Surgery
- Other Specialties Ophthalmology
- Location Canandaigua, NY
- Active Since 09/05/2006
- Last Updated 12/16/2021
- Taxonomy Code 207WX0200X
- Entity Type Individual
- NPI Number 1801998109
Products in Payments
- XIIDRA (Drug) $149.42
- BROLUCIZUMAB (Drug) $67.80
- TEPEZZA (Drug) $52.77
- Humira (Biological) $42.41
- MIEBO (Drug) $31.84
- VICTUS (Device) $24.30
- Simbrinza (Drug) $23.02
- Xeomin (Biological) $21.97
- RXSIGHT CONTACT LENS (Device) $19.93
- TEPEZZA (Biological) $15.79
- ACTHAR (Biological) $14.30
- AUVI-Q (Drug) $13.39
- Prokera (Device) $12.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.